Results for tag: "Havrix"

Havrix is a vaccine used to prevent hepatitis A, a viral infection that affects the liver. It is a inactivated virus vaccine, meaning it contains a dead virus that cannot cause infection. The vaccine is administered in two doses, six to twelve months apart. It is recommended for people who are at risk of contracting hepatitis A, such as travelers to certain countries, people with chronic liver disease, and people who use injection drugs. The Havrix market is composed of companies that produce and distribute the vaccine. These companies include GlaxoSmithKline, Merck, Sanofi Pasteur, and Pfizer. They are responsible for the research, development, manufacturing, and distribution of the vaccine. They also provide educational materials and support to healthcare providers and patients. Show Less Read more